492 related articles for article (PubMed ID: 20884158)
1. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182.
Kim CK; Lee Y; Lee H; Woo GJ; Song W; Kim MN; Lee WG; Jeong SH; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):432-8. PubMed ID: 20884158
[TBL] [Abstract][Full Text] [Related]
2. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
[TBL] [Abstract][Full Text] [Related]
4. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea.
Lee K; Kim MN; Choi TY; Cho SE; Lee S; Whang DH; Yong D; Chong Y; Woodford N; Livermore DM;
Int J Antimicrob Agents; 2009 Jun; 33(6):520-4. PubMed ID: 19091520
[TBL] [Abstract][Full Text] [Related]
5. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
6. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Mendes RE; Bell JM; Turnidge JD; Castanheira M; Jones RN
J Antimicrob Chemother; 2009 Jan; 63(1):55-9. PubMed ID: 18957398
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
[TBL] [Abstract][Full Text] [Related]
10. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
11. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
[TBL] [Abstract][Full Text] [Related]
12. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
13. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
14. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
15. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
16. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil.
Carvalho KR; Carvalho-Assef AP; Peirano G; Santos LC; Pereira MJ; Asensi MD
Int J Antimicrob Agents; 2009 Jul; 34(1):25-8. PubMed ID: 19216059
[TBL] [Abstract][Full Text] [Related]
17. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.
He C; Xie Y; Fan H; Kang M; Tao C; Zhang R; Hu Y; Chen Z; Wang L
Int J Antimicrob Agents; 2011 Sep; 38(3):257-60. PubMed ID: 21705198
[TBL] [Abstract][Full Text] [Related]
18. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Park YK; Jung SI; Park KH; Kim SH; Ko KS
Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
